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Aim. Congenital cystic adenomatoid lung malformation is a rare unilateral dysplasia of the lung. Three pathologic types are
described in the literature: type I with cysts >2cm, type II with cysts <1cm, and type III with microcysts. The aim of this paper
is to present a case of a fetus with congenital cystic adenomatoid lung malformation and discuss the necessity for pregnancy
termination according to its prognosis and future mortality. Case. A 36-year-old pregnant woman (para: 1, gravida: 1) presented
in our department for anatomy ultrasound screening at 20 + 1 weeks of gestation. The ultrasound detected a cystic adenomatoid
right lung malformation measuring 1.45 × 1.67cm which caused mediastinal shift of the heart and the lung to the left side. Other
ﬁndings were cysts of the choroid plexus and echogenic intracardiac foci. The parents after genetic counseling decided pregnancy
termination. The pregnant received cabergoline for ablactation. Conclusion. Congenital cystic adenomatoid lung malformation
has diﬀerent prognosis according to the type (69% in type I, 0% in types II and III). Fetal hydrops, cardiac and skeletal anomalies,
Potter’ssyndrome,andgastrointestinalatresiaarecommoncoﬁndings.Geneticcounselingisnecessary,andpregnancytermination
is proposed to the cases with poor prognosis.
1.Introduction
Congenital cystic adenomatoid lung malformation (CCAM)
is a rare, usually, unilateral dysplasia of the lung. The entity
was ﬁrst reported in 1787 with the description of the absence
of the lungs [1]. It results from an abnormal maturation of
the bronchopulmonary tree, especially an overgrowth of the
terminal bronchioles [2]. The etiology of the entity remains
unknown. Hamartomatous change in the terminal bron-
chioles or an arrest in their embryological development be-
tween7and15weeksofgestationissuspected[3].Decreased
apoptosis also plays a role [3]. The related genes in the
pathogenesis are HOXB5, Fgf7, and PDGFB [4, 5].
The incidence of CCAM ranges from 1:35,000 up
to 1:25,000 [6]. According to Rosado-de-Christenson and
Stocker, three pathologic types are described: type I: cysts
diameter >2cm, type II: cysts diameter <1cm, and type III:
microcysts [7]. In parallel, Adzick et al. diﬀerentiated CCAM
to macrocystic and microcystic types [8]. The aim of this
paper is to present a case of a fetus with congenital cystic
adenomatoid lung malformation and discuss the need for
pregnancy termination in the cases with poor prognosis.
2.Case
A 36-year-old pregnant woman (para: 1, gravida: 1) pre-
sented in our department for anatomy ultrasound screening
at 20 + 1 weeks of gestation. No problems are mentioned
in her medical or obstetric history. Her current pregnan-
cy was uncomplicated. The ultrasound detected a cystic
adenomatoid right lung malformation measuring 1.45 ×
1.67cm which caused mediastinal shift of the heart and
the lung to the left side (Figure 1). Other ﬁndings were
cysts of the choroid plexus, as well as echogenic intracardiac
foci. No polyhydramnios or hydrops fetalis were found.
The parents after genetic counseling (chromosome analysis)
decided pregnancy termination, although they were inform-
ed regarding the increased possibility of excellent prognosis.
The pregnant received cabergoline for ablactation.2 Case Reports in Medicine
Figure 1: Cystic adenomatoid right lung malformation.
3. Discussion
CCAM is a rather rare entity which is usually identiﬁed in
the anatomy ultrasound scanning of the second trimester.
Prenatal diagnosis of CCAM has increased due to the
advances in antenatal sonography. The positive predictive
value and the sensitivity of 2D sonographic evaluation range
between 45–57% and 70–81%, respectively [9]. Moreover,
the3Dsonographicevaluationallowsallcysticlesionswithin
the studied volume to be seen as opaque or echogenic [10].
MRI is another useful tool for imaging CCAM [11]. In our
case, the diagnosis was performed by using 2D ultrasound.
CCAM is usually unilateral [12]. The macrocystic type
has large cysts of variable size with thin echogenic areas,
whereas the microcystic type has a deﬁned echogenic area
with cysts <5mm in diameter [12]. In our case, a left unilat-
eral anechoic cyst <2cm was identiﬁed. Usually, no associa-
tion with aneuploidy is found, and for this reason kary-
otyping is not indicated. Although, in our case, the parents
opted for amniocentesis, the karyotype was normal. Some
patientsespeciallyoftypeICCAMdemonstratecompression
of the heart and the vena cava leading to mediastinal shift,
polyhydramnios, and fetal hydrops [13]. Moreover, skeletal
anomalies,Potter’ssyndrome,andgastrointestinalatresiaare
other common ﬁndings [14].
The diﬀerential diagnosis includes bronchopulmonary
sequestration, bronchogenic cyst, neurenteric cysts, congen-
ital lobar emphysema, and diaphragmatic hernia [11, 15].
The prognosis is usually optimal. Poor prognostic ﬁnd-
ings are hydrops fetalis, ascites, polyhydramnios, bilateral
lung involvement, and a ﬁnal lung-to-thorax transverse area
r a t i oo fl e s st h a n0 . 2 5[ 16, 17]. It should also be mentioned
that congenital cystic adenomatoid lung malformation has
diﬀerent prognosis according to the type (69% in type I, 0%
in types II and III). The cystic adenomatoid malformation
volume ratio—which is deﬁned as the estimated volume of
the CCAM divided by head circumference—is used to pre-
dict prognosis. A ratio >1.6, leads to a poorer prognosis [18].
In our case, the ratio was less than 1.6 and for this reason ter-
mination of pregnancy was not proposed, although the
parents opted diﬀerently.
Genetic counseling is necessary and pregnancy termina-
tion is frequently wrongly proposed due to “poor prognosis.”
The good prognosis could be explained by the fact that the
cyst decreases in size in utero in the majority of cases [19].
The peak CCAM growth is expected to occur by the 28th
gestational week and regression usually occurs in 20% of
cases after 29 weeks [19]. Women should be advised to give
birth in tertiary centres with a pediatric unit. Antenatal-
ly diagnosed CCAM has an excellent prognosis when signs
of severe fetal distress are absent. Nakata et al. showed
that, in cases with hydrops fetalis, fetal intervention is ne-
cessary [6]. Diﬀerent treatment techniques are proposed
in heavier cases such as shunting, laser, and postpartum
surgery. Fetal intervention such as cyst-amniotic shunting
or tumor resection before 32 weeks of gestation could also
be used [20]. Another in utero technique is percutaneous
laser ablation [21]. Tran et al. after a retrospective study of
34 cases with CCAM proposed that asymptomatic neonates
shouldhaveapostnatalCTeveniftheCCAMappearstohave
resolved or decreased on antenatal ultrasound [22]. How-
ever,in asymptomatic patients electiveoperation isproposed
in 3–6 months of life to avoid respiratory infections,
pneumothorax,orevenmalignancy[23],whileapartiallung
resection using an axillary skin crease incision is also pro-
posed to obtain a good postoperative quality of life [6]. Such
interventions are life saving. Although rare entities, the most
common relevant malignancies are bronchoalveolar cancer
and rhabdomyosarcoma [24, 25]. Usually, a lobectomy in
such cases is performed, and then the mortality rates range
f r o m9t o4 9 %[ 26].
In our case, the pregnant woman was advised not to ter-
minate the pregnancy; however, the couple decided to do so
because of the increased fear of developing a fetus with hy-
drops and comorbidity.
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